Senti Biosciences is trading at $0.34, up 7.6%, with the advance appearing primarily linked to broader biotechnology-sector strength.
- The sector rose 2.07% during regular trading amid optimism around AI-enabled drug discovery and positive clinical developments.
- Shares closed at $0.32 on September 22, 2026.
- No clear company-specific announcement or SEC filing dated September 22–23 explains the move; recent filings concern earlier financing and strategic transactions.